High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients.

Busse D, Simon P, Petroff D, El-Najjar N, Schmitt L, Bindellini D, Dietrich A, Zeitlinger M, Huisinga W, Michelet R, Wrigge H, Kloft C

Open source

DOI: 10.1128/aac.02302-21
Published: 2022 Jun 21
Container: Antimicrobial agents and chemotherapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1128/aac.02302-21,
  title = {High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients.},
  author = {Busse D and Simon P and Petroff D and El-Najjar N and Schmitt L and Bindellini D and Dietrich A and Zeitlinger M and Huisinga W and Michelet R and Wrigge H and Kloft C},
  year = {2022},
  journal = {Antimicrobial agents and chemotherapy},
  doi = {10.1128/aac.02302-21},
  url = {https://doi.org/10.1128/aac.02302-21}
}

RIS

TY  - JOUR
TI  - High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients.
AU  - Busse D
AU  - Simon P
AU  - Petroff D
AU  - El-Najjar N
AU  - Schmitt L
AU  - Bindellini D
AU  - Dietrich A
AU  - Zeitlinger M
AU  - Huisinga W
AU  - Michelet R
AU  - Wrigge H
AU  - Kloft C
PY  - 2022
JO  - Antimicrobial agents and chemotherapy
DO  - 10.1128/aac.02302-21
UR  - https://doi.org/10.1128/aac.02302-21
ER  -

APA

D, B., P, S., D, P., N, E., L, S., D, B., A, D., M, Z., W, H., R, M., H, W., & C, K. (2022). High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.02302-21

Source records

pubmed · retrieved 2026-09-26T13:18:10.814Z